Editas Medicine (EDIT) Other Operating Expenses (2016 - 2020)

Editas Medicine (EDIT) has reported Other Operating Expenses for 4 consecutive years, with $2000.0 the latest figure, recorded in Q4 2020.

• In Q4 2020, Other Operating Expenses rose 100.0% year-over-year to $2000.0; the TTM figure through Sep 2021 stood at $2000.0 (up 100.0% YoY), while the FY2016 annual figure was $40.5 million, changed N/A from the prior year.
• Other Operating Expenses climbed to $2000.0 in Q4 2020 per EDIT's latest filing, from $1000.0 in the prior quarter.
• Across five years, Other Operating Expenses topped out at $40.1 million in Q4 2017 and bottomed at $1000.0 in Q4 2019.
• Historically, Other Operating Expenses has averaged $12.6 million across 4 years, with a median of $5.2 million in 2016.
• Annual changes were most pronounced in 2017 — Other Operating Expenses soared 288.09% — and 2020, when it jumped 100.0%.
• Editas Medicine's Other Operating Expenses stood at $10.3 million in 2016, then jumped by 288.09% to $40.1 million in 2017, then slumped by 100.0% to $1000.0 in 2019, then surged by 100.0% to $2000.0 in 2020.
• Business Quant data shows EDIT's Other Operating Expenses at $2000.0 in Q4 2020, $1000.0 in Q4 2019, and $40.1 million in Q4 2017.